Positive inotropic effects of carbon monoxide‐releasing molecules (CO‐RMs) in the isolated perfused rat heart
Authors:
Open Access
- 1 December 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 149 (8) , 1104-1112
Abstract
Background and purpose: Carbon monoxide (CO) generated by the enzyme haeme oxygenase‐1 (HO‐1) during the breakdown of haeme is known to mediate a number of biological effects. Here, we investigated whether CO liberated from two water soluble carbon monoxide‐releasing molecules (CO‐RMs) exerts inotropic effects on the myocardium.Experimental approach: Rat isolated hearts perfused either at constant flow or constant pressure were used to test the effect of CO‐RMs.Key results: CORM‐3, a fast CO releaser, produced a direct positive inotropic effect when cumulative doses (3, 10 and 30 μg min−1) or a single dose (5 μM) were infused at either constant coronary pressure (CCP) or constant coronary flow (CCF). The inotropic effect mediated by CORM‐3 was abolished by blockade of soluble guanylate cyclase or Na+/H+ exchanger, but not by inhibitors of L‐type Ca2+ channels and protein kinase C. CORM‐3 also caused a slight reduction in heart rate but did not alter coronary flow. In contrast, the slow CO releaser CORM‐A1 produced significant coronary vasodilatation when given at the highest concentration (30 μg min−1) but exerted no effect on myocardial contractility or heart rate.Conclusion and implications: A rapid CO release from CORM‐3 exerts a direct positive inotropic effect on rat isolated perfused hearts, whereas CO slowly released by CORM‐A1 had no effect on myocardial contractility but caused significant coronary vasodilatation. Both cGMP and Na+/H+ exchange appear to be involved in this effect but further work is needed to determine the relative contribution of each pathway in CO‐mediated inotropic effect.British Journal of Pharmacology (2006) 149, 1104–1112. doi:10.1038/sj.bjp.0706939Keywords
This publication has 56 references indexed in Scilit:
- Therapeutic applications of carbon monoxide-releasing moleculesExpert Opinion on Investigational Drugs, 2005
- Heme Oxygenase-1–Related Carbon Monoxide and Flavonoids in Ischemic/Reperfused Rat RetinaInvestigative Ophthalmology & Visual Science, 2004
- Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS PathwaysArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Carbon monoxide exposure in rat heart: evidence for two modes of toxicityBiochemical and Biophysical Research Communications, 2004
- Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Heme oxygenase‐1 related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardiumThe FASEB Journal, 2003
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger GasesAnnual Review of Pharmacology and Toxicology, 1997
- Selective Guanylyl Cyclase Inhibitor Reverses Nitric Oxide-Induced VasorelaxationHypertension, 1997
- Amiloride and its analogs as tools in the study of ion transportThe Journal of Membrane Biology, 1988